Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification to enhance binding affinity to specific enzyme targets. Commonly employed in medicinal chemistry for constructing potent, targeted therapies in oncology research. Also utilized in the preparation of bioactive molecules where controlled substitution on the pyrrolopyridine core is required for optimal pharmacological activity.